NEW CFO Wedgie breakEarnings TOMMOROW new CFO appointed worked with ATAI previously where he led a 225M initial public offering in 2021. Projections look good
ALT trade ideas
Wyckoff Bullish Patterns - Dollar getting stronger! Easy MoneyICEUS:DX1!
Dollar getting stronger on daily and weekly chart! Wyckoff Wave Indicator shows the power of buyers who are taking control.
How Wyckoff Wave Indicator works?
The Wyckoff Wave Indicator and the Weis Wave Indicator are both technical analysis tools derived from the principles of Richard D. Wyckoff, a pioneer in the field of market analysis. Here’s a breakdown of each:
Wyckoff Wave Indicator
The Wyckoff Wave Indicator is designed to track the cumulative volume flow of the market. It helps traders understand the underlying strength or weakness by showing the overall trend of buying and selling pressure. The indicator accumulates volume with price movement to depict the market's overall sentiment. Key features include:
Volume Analysis: It considers the volume associated with price movements, indicating whether the market is being driven by strong buying or selling.
Trend Identification: It helps in identifying the primary trend of the market, whether it's bullish, bearish, or sideways.
Divergence Signals: It can show divergences between price movements and volume flow, providing potential reversal signals.
Weis Wave Indicator
The Weis Wave Indicator is a more modern adaptation of Wyckoff's principles, developed by David Weis. It simplifies volume analysis by plotting cumulative volume as waves, making it easier to visualize the flow of buying and selling pressure. Key features include:
Wave Calculation: It aggregates volume over price waves, making it easier to see the ebb and flow of market pressure.
Wave Counts: By tracking the volume associated with each wave, traders can see whether buyers or sellers are dominating.
Market Structure: It helps in understanding the market structure by breaking down movements into distinct waves, each associated with specific volume patterns.
Comparison
Purpose: Both indicators aim to analyze volume in relation to price movements, providing insights into market strength and potential reversals.
Visualization: The Wyckoff Wave Indicator typically presents cumulative volume in a straightforward manner, while the Weis Wave Indicator uses wave patterns for a more intuitive visual representation.
Application: Both indicators are used in conjunction with other Wyckoff principles and tools to develop a comprehensive market analysis strategy.
Usage in Trading
Identify Trends: Both indicators help in determining the dominant market trend, which is crucial for making informed trading decisions.
Spot Reversals: By analyzing volume flow, traders can spot potential reversals ahead of time, improving their entry and exit points.
Confirm Breakouts: The indicators can confirm the validity of breakouts or breakdowns by showing whether there is sufficient volume to support the move.
Tools and Platforms
VolumeDayTrader offers script of such indicators on TradingView. For more details check our profile or DM us.
ALT | Heavy Accumulation in Progress | LONGAltimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
ALT Altimmune Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ALT Altimmune prior to the earnings report this week,
I would consider purchasing the 9usd strike price at the money Calls with
an expiration date of 2024-6-21,
for a premium of approximately $2.22.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
ALT is a stockALT is a stock in the pharmaceutical and weight-loss drug sector.
It was recommended by a friend.It can be followed for the long term.
Weekly MACD has recently moved into a sell position.
It's not yet at the buying point.
There is a decrease in weekly and Monthly volüme.
Nice breakout from a falling wedge on $ALTBreakout from falling wedge at very high volume.
This is a GREEN ANT stock NASDAQ:ALT
long ALT Entry pointit might be ridiculous to say but if price were to fall back to 9-10 which even if it were too due to its massive runup in price. A retracement in current price action would only provide another opportunity long if one were to present itself. Currently the chart the left is the daily timeframe and the right is the weekly, currently we are in a range of a possible breakout if price were to breach 12.03-12.07 maintain hold next price target high 12s and hold. If the current hype turns out to be a bust i would re evaluate the entry. We are currently in overbought region based on the Rsi on the very bottom right.
On the weekly Rsi indicator we are currently in overbought region so lets expect a price retracement of atleast 16 percent so an ideal buy in target on bullish support would be 9.50.
ALT Altimmune Options Ahead of EarningsAnalyzing the options chain and the chart patterns of ALT Altimmune prior to the earnings report this week,
I would consider purchasing the 3.00usd strike price Puts with
an expiration date of 2024-1-19,
for a premium of approximately $0.99.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
Altimmune , you better leave this sinking titanic Altimmune had a good run, but right now it's sinking faster than the Titanic. It breached both the 100 and 200 MA on H4 and is on its way down to around $5.
Long scalp ALTBased on its uptrend, rebound from support and a familiar chart pattern confirmed by my technical indicators, I expect at least half a percent in profits IF
ALT exceeds Friday's high of $20.94 during Monday's session.
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND fALT: Altimmune, Inc
2022-01-31 07:00:00
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Altimmune Announces Positive Results From 12-week Phase 1 ClinicALT: Altimmune, Inc
2021-09-28 07:01:00
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers
Long | ALTNASDAQ:ALT
Possible Scenario: LONG
Evidence: Price Action,
TP1: 15.50$ to fill the gap
Call options, Strike 16$, 10/15/2021
Call options, Strike 18$, 10/15/2021
Call options, Strike 19$, 10/15/2021
*This is my idea and could be wrong 100%.
ALT Breakout to $16.00I am bullish on ALT due to confluence. Option Open Interest shows a wall at £12.00 and $16.00 . EMA 9/50/200 consolidating around 13.50-14.50 where the down trend line meets all 3. As well as the up trend line indicating a pressure point. MACD is giving a buy signal. Bollinger Bands and Donchian Channels are both funneled into this pressure point (both suggest a small drop as price action is at the upper deviation line of both indicators). Getting in on the 20th Apr 2021 looks to have been an ideal entry point if a break out is to pop in the coming week. There is a chance for price action to drop towards the $12.00 before going back up to $16.00 (hopefully).
- Just My Opinion -
ALT Price Targets with Expected Resistance and SupportsLabeled are the price targets for the breakout uptrend.
The ascending stop loss would be used when each level has been used as support.
Altimmune Announces FDA Clearance of AdCOVID™ IND Application!!!ALT: Altimmune, Inc.
2021-02-17 07:02:00
Altimmune Announces FDA Clearance of AdCOVID™ IND Application
ALT huge opportunity if you play it rightI want to see a rejection off the 0.618 fib and rests on the support for a huge run to the 1.618 around $43-60
MACD looking bullish, RSI going up. MACD is widening green and RSI is heading up. 50 sma line is below the 200 sma line so i will wait for the golden cross to occur to open a position. Looking into the company this is a long hold for me. Not a financial advisor.
